Akademisyen
ŞULE MİNE BAKANAY ÖZTÜRK
PROFESÖR
ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 47
- Proje 0
- Kitap 0
- Bildiri 30
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
2
Q2
7
Q3
13
Q4
3
WoS (JCR)
Q1
2
Q2
2
Q3
10
Q4
8
TR Index
5
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
41.2%
Üst %1 payı
0.0%
Üst %10 payı
3.6%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic ThrombocytopenicPurpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 12.0%
- 2024 A young adult patient with Philadelphia positive acute lymphoblastic leukemia presenting with extreme hyperleukocytosis YÖKSİS SJR Q4 JCR Q3 OpenAlex 63.2%
- 2023 Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia YÖKSİS SJR Q3 OpenAlex 61.5%
- 2023 Comparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients YÖKSİS TR Index OpenAlex 32.0%
- 2022 Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 58.1%
- 2021 Evaluation of Bone Mineral Densitometry Measurements in Patients with BCR/ABL-Negative Chronic Myeloproliferative Neoplasm YÖKSİS OpenAlex 48.1%
- 2020 The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.6%
- 2020 Does the platelet‑to‑lymphocyte ratio have a prognostic effect in patients with myelodysplastic syndrome? YÖKSİS SJR Q3 JCR Q3 OpenAlex 71.2%
- 2020 Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera YÖKSİS SJR Q3 JCR Q4 OpenAlex 41.0%
- 2020 VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience YÖKSİS OpenAlex 48.5%
- 2019 Thiol – disulphide homeostasis in polycythemia vera - Polistemia vera olgularında thiol-disülfid homeostasis YÖKSİS OpenAlex 7.4%
- 2019 PB1886 THE TRANSMEMBRANE RECEPTOR TYROSINE KINASE‐LIKE ORPHAN RECEPTOR 1 IN CHRONIC LYMPHOCYTIC LEUKEMIA YÖKSİS SJR Q3 JCR Q1
- 2019 Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib YÖKSİS SJR Q3 JCR Q4 OpenAlex 67.3%
- 2019 Single-center experience: comparison of reduced intensive chemotherapy and low-dose cytarabine treatment as remission induction in older age aml cases YÖKSİS SJR Q2 JCR Q3 OpenAlex 12.7%
- 2019 In myelodysplastic syndrome cases, what should be the level of ferritin which has prognostic value? YÖKSİS SJR Q3 JCR Q4 OpenAlex 58.0%
- 2019 PB2171 THE COMPARISON OF THE RELATIONSHIP BETWEEN POLYNEUROPATHY FREQUENCY AND CLINICAL AND LABORATORY FINDINGS IN MULTIPLE MYELOMA CASES YÖKSİS SJR Q3 JCR Q1
- 2019 Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic? YÖKSİS SJR Q4 JCR Q4 OpenAlex 9.5%
- 2019 AUER RODS IN MATURE NEUTROPHILS IN A CASE OF ACUTE PROMYELOCYTIC LEUKEMIA YÖKSİS OpenAlex 38.5%
- 2019 Thiol-disulphide homeostasis in essential thrombocythemia patients YÖKSİS SJR Q3 JCR Q3 OpenAlex 56.8%
- 2019 Effect of Treatment on the Muscle Mass and Response to Therapy in Hodgkin\u2019s Lymphoma YÖKSİS TR Index OpenAlex 4.4%